🇺🇸 FDA

Company profile · Sponsor

BRAINSTORM

BRAINSTORM CELL THERAPEUTICS INC.

BCLI · NYSE biotech NEW YORK, NY, USA
Pipeline
5
Drugs
0
Patents
8

Quick answer

BRAINSTORM (BCLI) is a biotech company. headquartered in NEW YORK, NY, USA. listed on NYSE. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker BCLI
Exchange NYSE
Company type biotech
Headquarters NEW YORK, NY, USA
SEC CIK 0001137883

Pipeline (5)

Search pipeline →

  1. Debamestrocel - MSC-NTF (NurOwn)

    BRAINSTORM

    Amyotrophic Lateral Sclerosis (ALS)

    phase 3 mab active

    1 trial

  2. NurOwn® (MSC-NTF cells)

    BRAINSTORM

    Amyotrophic Lateral Sclerosis (ALS)

    phase 3 mab completed

    2 trials

  3. MSC-NTF cells transplantation (IM)

    BRAINSTORM

    Amyotrophic Lateral Sclerosis

    phase 2 mab completed

    1 trial

  4. MSC_NTF cells transplantation by multiple intramuscular injections at 24 separate sites, in addition to a single intrathechal injection into the CSF

    BRAINSTORM

    Amyotrophic Lateral Sclerosis

    phase 2 mab completed

    1 trial

  5. NurOwn (MSC-NTF cells)

    BRAINSTORM

    Multiple Sclerosis, Chronic Progressive

    phase 2 mab completed

    1 trial

Patents (8)

Search patents →

  1. US 12233092

    MSC-NTF specific exosomes and use thereof

    Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11185572

    Mesenchymal stem cells for the treatment of CNS diseases

    Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10564149

    Populations of mesenchymal stem cells that secrete neurotrophic factors

    Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10052363

    Mesenchymal stem cells for the treatment of CNS diseases

    Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10046010

    Methods of generating mesenchymal stem cells which secrete neurotrophic factors

    Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9474787

    Mesenchymal stem cells for the treatment of CNS diseases

    Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8900574

    Mesenchymal stem cells for the treatment of CNS diseases

    Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8663987

    Mesenchymal stem cells for the treatment of CNS diseases

    Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is BRAINSTORM?

BRAINSTORM (BCLI) is a biotech company. headquartered in NEW YORK, NY, USA. listed on NYSE. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does BRAINSTORM sponsor?

We track 5 ClinicalTrials.gov-linked programs for BRAINSTORM, including Debamestrocel - MSC-NTF (NurOwn) and 4 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does BRAINSTORM company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.